Replies to post #5944 on Kedem Pharmaceuticals, Inc.(fka KDMP)

[legendsfirm]

I have been in GHLV/KDMP for almost 2 years. SUBLINGUAL is the key. Salari and company own the patent/rights to this method(SUBLINGUAL). Based on studies, sublingual requires less of a dose (better for internal human body), faster treatment, and more.

The big Pharma boys are going to want this delivery method. Well the only way to get it is to buy us all out for a lot of money.